Trial Profile
Single-centre cohort study of bortezomib in patients with refractory systemic lupus erythematosus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary)
- Indications Systemic lupus erythematosus
- Focus Therapeutic Use
- 03 Dec 2015 New trial record